Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Cue Biopharma (CUE): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
8 analysts
Options Flow (P/C)
0.00
More calls — Bullish
Avg Consensus PT
$127
+667.5%
Highest Price Target
$300
+1718.2%
Lowest Price Target
$60
+263.6%
Short Interest
10.2%
Rising — Bearish
Insider Activity (30d)
Net Seller
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | B. Riley Securities | Mayank Mamtani— | +403.0% | $83 | Initiate | Buy |
| Aug 25, 2025 | LUCID CAPITAL MARKETS | Dev Prasad — | -75.8% | $4 | Initiate | Buy |